Bellerophon Therapeutics/ US0787711029 /
2023-10-13 9:59:59 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.11USD | - | 35,527 Turnover: 4,093.74 |
-Bid Size: - | -Ask Size: - | 0.39 | 0.08 |
GlobeNewswire
2023-12-26
Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technolo...
GlobeNewswire
2021-12-17
Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for...
GlobeNewswire
2021-11-15
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire
2021-09-07
Bellerophon to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
2021-08-05
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2021 Financial Results
GlobeNewswire
2021-05-26
Bellerophon Appoints Naseem Amin, M.D. as Chairman of its Board of Directors
GlobeNewswire
2021-05-11
Bellerophon Provides Clinical Program Update and Reports First Quarter 2021 Financial Results
GlobeNewswire
2021-03-11
Bellerophon Provides Clinical Program Update and Reports Fourth Quarter and Full-Year 2020 Financial...
GlobeNewswire
2021-03-02
Bellerophon to Present at the H.C. Wainwright Global Life Sciences Conference
GlobeNewswire
2021-01-04
Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
GlobeNewswire
2020-12-30
Ekso Bionics’ Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors
GlobeNewswire
2020-12-01
Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpul...
GlobeNewswire
2020-11-23
Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse®...
GlobeNewswire
2020-11-05
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
GlobeNewswire
2020-10-29
Bellerophon to Present Results from its Phase 2 iNO-PF Study of INOpulse® for the Treatment of Fibro...
GlobeNewswire
2020-08-11
Bellerophon Appoints Cardiopulmonary Disease Expert Wassim Fares, M.D., MSCR, as Chief Medical Offic...
GlobeNewswire
2020-08-05
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results
GlobeNewswire
2020-07-15
Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Jo...